Cargando…

Parenteral Nutrition Associated Hepatic Steatosis and NAFLD Intersect at AMPK

Detalles Bibliográficos
Autor principal:	Guthrie, Gregory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421576/ https://www.ncbi.nlm.nih.gov/pubmed/35810785 http://dx.doi.org/10.1016/j.jcmgh.2022.06.005

Ejemplares similares

Liver PP2A-Cα Protects From Parenteral Nutrition-associated Hepatic Steatosis
por: Maitiabula, Gulisudumu, et al.
Publicado: (2022)

Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD
por: Gonzalez, Concepcion, et al.
Publicado: (2013)

Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
por: Bernhardt, Philipp, et al.
Publicado: (2018)

Miltefosine Suppresses Hepatic Steatosis by Activating AMPK Signal Pathway
por: Fang, Ru, et al.
Publicado: (2016)

Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway
por: Tong, Junlu, et al.
Publicado: (2022)

Selenoneine Ameliorates Hepatocellular Injury and Hepatic Steatosis in a Mouse Model of NAFLD
por: Miyata, Masaaki, et al.
Publicado: (2020)

Supplemental parenteral nutrition: decisions based on weak evidence
por: Arends, Jann, et al.
Publicado: (2020)

MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
por: Segura-Azuara, Nancy de los Ángeles, et al.
Publicado: (2022)

Iron metabolism mediates the relationship between Vitamin C and hepatic steatosis and fibrosis in NAFLD
por: Hu, Zhengyu, et al.
Publicado: (2022)

A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD
por: Ashworth, William B., et al.
Publicado: (2016)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Acupuncture improved hepatic steatosis in HFD-induced NAFLD rats by regulating intestinal microbiota
por: Wang, Haiying, et al.
Publicado: (2023)

Lactobacillus johnsonii Attenuates Liver Steatosis and Bile Acid Dysregulation in Parenteral Nutrition-Fed Rats
por: Xu, Juan, et al.
Publicado: (2023)

Modelling porcine NAFLD by deletion of leptin and defining the role of AMPK in hepatic fibrosis
por: Tan, Tan, et al.
Publicado: (2023)

Phyllanthus emblica aqueous extract retards hepatic steatosis and fibrosis in NAFLD mice in association with the reshaping of intestinal microecology
por: Luo, Xiaomin, et al.
Publicado: (2022)

Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis
por: Shih, Ping-Hsiao, et al.
Publicado: (2021)

IGFBP-2 as a biomarker in NAFLD improves hepatic steatosis: an integrated bioinformatics and experimental study
por: Chen, Xu, et al.
Publicado: (2021)

Parenteral nutrition associated cholestasis
por: Costa, Simonetta, et al.
Publicado: (2015)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery
por: Chen, Jiaqi, et al.
Publicado: (2022)

HADHA alleviates hepatic steatosis and oxidative stress in NAFLD via inactivation of the MKK3/MAPK pathway
por: Ding, Jiexia, et al.
Publicado: (2022)

Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort
por: Beyer, Cayden, et al.
Publicado: (2021)

Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and β-oxidation
por: Du, Tingwan, et al.
Publicado: (2023)

Risk Stratification of Advanced Fibrosis in HIV Patients With Hepatic Steatosis Using the NAFLD Fibrosis and BARD Scores
por: YENDEWA, George A., et al.
Publicado: (2023)

Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice
por: Luo, Li, et al.
Publicado: (2019)

Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway
por: Li, Liuran, et al.
Publicado: (2021)

How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
por: Yu, Jung Hwan, et al.
Publicado: (2019)

Downregulation of hepatic ceruloplasmin ameliorates NAFLD via SCO1-AMPK-LKB1 complex
por: Xie, Liping, et al.
Publicado: (2022)

Effects of cyclic parenteral nutrition on parenteral-associated liver dysfunction parameters
por: Arenas Villafranca, Jose J., et al.
Publicado: (2017)

Nutritional Approaches in Children with Overweight or Obesity and Hepatic Steatosis
por: Spiezia, Chiara, et al.
Publicado: (2023)

Can hepatic steatosis really promote hepatitis B viral hepatocarcinogenesis? The jury is out on.
por: Kim, Won
Publicado: (2019)

How to prescribe parenteral nutrition the safest way: case by case or using machine learning?
por: Singer, Pierre
Publicado: (2022)

Parenteral Nutrition Overview
por: Berlana, David
Publicado: (2022)

Parenteral nutrition: Revisited
por: Chowdary, Koneru Veera Raghava, et al.
Publicado: (2010)

Parenteral and enteral nutrition /
por: Silberman, Howard
Publicado: (1989)

Standardised Parenteral Nutrition
por: Simmer, Karen, et al.
Publicado: (2013)

Parenteral Nutrition and Lipids
por: Raman, Maitreyi, et al.
Publicado: (2017)

AgNPs Aggravated Hepatic Steatosis, Inflammation, Oxidative Stress, and Epigenetic Changes in Mice With NAFLD Induced by HFD
por: Wen, Ling, et al.
Publicado: (2022)

Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress
por: Palladini, Giuseppina, et al.
Publicado: (2019)

Losartan Prevents Hepatic Steatosis and Macrophage Polarization by Inhibiting HIF-1α in a Murine Model of NAFLD
por: Wang, Cheng-Hui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rtcgpl636kt2sa6k6rsekp0e8e